FFAR4 and breast carcinoma: The altered fatty acid profiles indicated that despite fatty acid expenditure, certain long-chain fatty acids were preserved, or de novo synthesized during breast tumorigenesis and progression, and thus may serve as ligands for FFAR4 and affect breast cancer biology and patient outcome.